These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31924743)

  • 1. Metabolic dysregulation in the
    Wooton-Kee CR; Robertson M; Zhou Y; Dong B; Sun Z; Kim KH; Liu H; Xu Y; Putluri N; Saha P; Coarfa C; Moore DD; Nuotio-Antar AM
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2076-2083. PubMed ID: 31924743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models.
    Mi X; Li Z; Yan J; Li Y; Zheng J; Zhuang Z; Yang W; Gong L; Shi J
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165842. PubMed ID: 32446740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Steatosis in the Mouse Model of Wilson Disease Coincides with a Muted Inflammatory Response.
    Gottlieb A; Dev S; DeVine L; Gabrielson KL; Cole RN; Hamilton JP; Lutsenko S
    Am J Pathol; 2022 Jan; 192(1):146-159. PubMed ID: 34627751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein is elevated in liver and duodenum of Atp7b
    Zhang CC; Volkmann M; Tuma S; Stremmel W; Merle U
    Biometals; 2018 Aug; 31(4):617-625. PubMed ID: 29732486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In
    Sharma Y; Liu J; Kristian KE; Follenzi A; Gupta S
    Gene Expr; 2018 Dec; 19(1):15-24. PubMed ID: 30029699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systems approach implicates nuclear receptor targeting in the Atp7b(-/-) mouse model of Wilson's disease.
    Wilmarth PA; Short KK; Fiehn O; Lutsenko S; David LL; Burkhead JL
    Metallomics; 2012 Jul; 4(7):660-8. PubMed ID: 22565294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying factors and phenotypic diversity in Wilson's disease.
    Lutsenko S
    Ann N Y Acad Sci; 2014 May; 1315():56-63. PubMed ID: 24702697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
    Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
    J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization of the therapeutic efficacy of a gene correction approach in Wilson's disease by laser-ablation inductively coupled mass spectrometry.
    Moreno D; Murillo O; Gazquez C; Hernandez-Alcoceba R; Uerlings R; Gonzalez-Aseguinolaza G; Weiskirchen R
    J Hepatol; 2018 May; 68(5):1088-1090. PubMed ID: 29317295
    [No Abstract]   [Full Text] [Related]  

  • 10. Comprehensive and comparative exploration of the Atp7b
    Lacombe M; Jaquinod M; Belmudes L; Couté Y; Ramus C; Combes F; Burger T; Mintz E; Barthelon J; Leroy V; Poujois A; Lachaux A; Woimant F; Brun V
    Metallomics; 2020 Feb; 12(2):249-258. PubMed ID: 31815268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging copper metabolism imbalance in Atp7b (-/-) knockout mouse model of Wilson's disease with PET-CT and orally administered 64CuCl2.
    Peng F; Lutsenko S; Sun X; Muzik O
    Mol Imaging Biol; 2012 Oct; 14(5):600-7. PubMed ID: 22170165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B.
    Leng Y; Li P; Zhou L; Xiao L; Liu Y; Zheng Z; Qin F; Hao Q; Xu H; Yao S; Dong B
    Hum Gene Ther; 2019 Dec; 30(12):1494-1504. PubMed ID: 31668086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent changes of cerebral copper metabolism in Atp7b
    Xie F; Xi Y; Pascual JM; Muzik O; Peng F
    Metab Brain Dis; 2017 Jun; 32(3):717-726. PubMed ID: 28130615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.
    Cai H; Cheng X; Wang XP
    Hepatology; 2022 Oct; 76(4):1046-1057. PubMed ID: 35340061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease.
    Wooton-Kee CR
    Pharmacol Ther; 2023 Nov; 251():108529. PubMed ID: 37741465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease.
    Roybal JL; Endo M; Radu A; Gray L; Todorow CA; Zoltick PW; Lutsenko S; Flake AW
    Gene Ther; 2012 Nov; 19(11):1085-94. PubMed ID: 22158007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography of copper metabolism in the Atp7b-/- knock-out mouse model of Wilson's disease.
    Peng F; Lutsenko S; Sun X; Muzik O
    Mol Imaging Biol; 2012 Feb; 14(1):70-8. PubMed ID: 21327972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragmentation of mitochondrial cardiolipin by copper ions in the Atp7b-/- mouse model of Wilson's disease.
    Yurkova IL; Arnhold J; Fitzl G; Huster D
    Chem Phys Lipids; 2011 Jul; 164(5):393-400. PubMed ID: 21645498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atp7b-/- mice as a model for studies of Wilson's disease.
    Lutsenko S
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1233-8. PubMed ID: 19021531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term metabolic correction of Wilson's disease in a murine model by gene therapy.
    Murillo O; Luqui DM; Gazquez C; Martinez-Espartosa D; Navarro-Blasco I; Monreal JI; Guembe L; Moreno-Cermeño A; Corrales FJ; Prieto J; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
    J Hepatol; 2016 Feb; 64(2):419-426. PubMed ID: 26409215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.